Advertisement

Topics

Novartis drug shows huge promise in cutting heart attack deaths

06:55 EST 14 Nov 2017 | pharmaphorum

Novartis look to have a major new treatment for heart disease on its hands, in the shape of canakinumab, a drug which has produced exceptional results in a new phase 3 trial. Canakinumab works by reducing inflammation in the body, and is already m...

Original Article: Novartis drug shows huge promise in cutting heart attack deaths

NEXT ARTICLE

More From BioPortfolio on "Novartis drug shows huge promise in cutting heart attack deaths"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...